Novel Mechanisms and Advancing Therapeutic Paradigms for Optimizing Real World Management of Hypercholesterolemia - Applying LDL-Targeted Therapies for CV Risk Reduction to the Front Lines of Cardiovascular, Diabetes, and Internal Medicine - Q&A